Grinspoon noted that even incremental reductions in blood pressure incidence can translate into meaningful declines in ...

The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone. IRP is a ...

In Perioperative Immunotherapy Advances: Insights from CheckMate-77T and KEYNOTE-671, our panel delves into the following ...

The 2018 opening of a Level 1 trauma center at the University of Chicago Medical Center was associated with a significant reduction in firearm-related mortality in a long-standing urban “trauma desert ...

Steven Grinspoon, MD, is the chief of the Metabolism Unit at Massachusetts General Hospital, director of the Nutrition Obesity Research Center and professor of medicine at Harvard Medical School. The ...

Patients exposed to nurse understaffing are more likely to experience higher rates of in-hospital mortality and 30-day readmission rates. These findings, published in JAMA Network Open, underscore the ...

COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...

MA grocery card use was associated with modest increases in wellness, primary care, and specialist visits among dual-eligible ...

Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for ...

This episode provides concluding perspectives on the evolving management of HER2-mutant non-small cell lung cancer (NSCLC). Panelists highlight the remarkable advances in recent y ...

Cost concerns among GLP-1 users extend beyond individual financial strain to perceptions of broader health care system sustainability. More than 70% of respondents supported minimum coverage ...

Acalabrutinib (Calquence; AstraZeneca) demonstrated a more modest ORR of 40% in a smaller 25-patient cohort, with median progression-free survival (PFS) of 3.2 months. While less robust than ...